"Mercy Health Saint Mary's is an integrated health care network offering a unique combination of capabilities to deliver a health care experience that offers both compassionate care and medical expertise. Our commitment to offer the latest technology and most highly skilled physicians in a holistic, patient-centered environment has made us a progressive leader in neuroscience, cardiovascular and cancer care, orthopedics, diabetes and endocrine care, kidney transplants, and integrative medicine."

During the past decade, Mercy Health Saint Mary's conducted 167 clinical trials. In the 10-year time frame, 167 clinical trials started and 128 clinical trials were completed, i.e. on average, 76.6% percent of trials that started reached the finish line to date. In the past 5 years, 68 clinical trials started and 77 clinical trials were completed. i.e. 113.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Health Saint Mary's" #1 sponsor was "National Cancer Institute (NCI)" with 127 trials, followed by "SWOG Cancer Research Network" with 35 trials sponsored, "Alliance for Clinical Trials in Oncology" with 30 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 21 trials sponsored and "NRG Oncology" with 21 trials sponsored. Other sponsors include 60 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Health Saint Mary's" #1 collaborator was "National Cancer Institute (NCI)" with 135 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 75 different institutions and companies that were collaborators in the rest 58 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Health Saint Mary's" are "Recurrent Breast Carcinoma" (10 trials), "Invasive Breast Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Breast Cancer" (8 trials) and "Stage IV Breast Cancer AJCC v6 and v7" (8 trials). Many other conditions were trialed in "Mercy Health Saint Mary's" in a lesser frequency.

Most popular intervention types in "Mercy Health Saint Mary's" are "Drug" (231 trials), "Other" (174 trials), "Biological" (97 trials), "Procedure" (62 trials) and "Radiation" (50 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (88 trials), "Quality-of-Life Assessment" (71 trials), "Questionnaire Administration" (50 trials), "Paclitaxel" (33 trials) and "Carboplatin" (30 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Health Saint Mary's" are 222 trials for "All" genders, 59 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy Health Saint Mary's". undefined are not yet recruiting, 68 are recruiting, 113 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 82 completed trials in Mercy Health Saint Mary's, 7 suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Health Saint Mary's, 9 "Phase 1" clinical trials were conducted, 131 "Phase 2" clinical trials and 152 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".